Vertex Pharmaceuticals Inc / Ma Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 0.10B0.14B1.41B1.53B1.21B0.58B1.03B1.70B2.49B3.05B4.16B6.21B7.57B8.93B9.87B11.02B
Cost of Revenue 0.06B0.24B0.09B0.04B0.12B0.21B0.28B0.41B0.55B0.74B0.90B1.08B1.26B1.53B
Gross Profit 0.10B0.14B1.35B1.29B1.12B0.54B0.92B1.49B2.21B2.64B3.62B5.47B6.67B7.85B8.61B9.49B
Operating items
Research & Development 0.55B0.64B0.71B0.77B0.88B0.86B1.00B1.05B1.32B1.42B1.75B1.64B1.94B2.54B3.16B3.63B
Selling, General & Administrative 0.13B0.19B0.40B0.43B0.36B0.31B0.38B0.43B0.50B0.56B0.66B0.77B0.84B0.94B1.14B1.46B
Restructuring Costs 0.01B0.00B0.00B0.00B0.04B0.05B0.00B0.00B0.01B-0.00B
Other Operating Expenses 0.03B0.01B0.19B0.28B0.54B0.06B0.12B0.21B0.53B0.44B0.55B0.93B2.01B1.14B1.74B6.16B
Operating Expenses 0.72B0.84B1.30B1.48B1.82B1.27B1.50B1.69B2.37B2.41B2.97B3.35B4.79B4.62B6.04B11.25B
Operating Income -0.61B-0.70B0.11B0.05B-0.61B-0.69B-0.47B0.01B0.12B0.64B1.20B2.86B2.78B4.31B3.83B-0.23B
EBIT -0.61B-0.70B0.11B0.05B-0.61B-0.69B-0.47B0.01B0.12B0.64B1.20B2.86B2.78B4.31B3.83B-0.23B
Non-operating items
Non Operating Investment Income -0.00B-0.04B-0.02B
Interest & Investment Income 0.01B0.00B-0.04B-0.02B-0.02B-0.07B-0.08B-0.08B0.01B0.04B0.06B0.02B0.00B0.14B0.61B0.60B
Other Non Operating Income 0.01B0.00B-0.02B0.00B0.01B0.03B-0.01B0.00B-0.08B-0.00B0.19B0.30B0.00B-0.16B-0.02B-0.09B
Non Operating Income 0.00B0.00B-0.02B0.00B0.01B0.03B-0.01B0.00B-0.08B-0.00B0.19B0.30B0.00B-0.16B-0.02B-0.09B
Net income details
EBT -0.64B-0.75B0.06B0.03B-0.63B-0.73B-0.56B-0.07B-0.02B0.60B1.39B3.12B2.73B4.23B4.38B0.25B
Tax Provisions 0.02B-0.00B-0.12B0.01B0.03B0.02B-0.11B-1.49B0.22B0.41B0.39B0.91B0.76B0.78B
Profit After Tax -0.64B-0.75B0.04B-0.11B-0.69B-0.74B-0.59B-0.11B0.26B2.10B1.18B2.71B2.34B3.32B3.62B-0.54B
Net Income - Minority -0.14B-0.20B-0.02B-0.15B-0.18B-0.01B
Income from Non-Controlling Interests 0.01B0.06B-0.24B-0.00B-0.03B0.03B-0.17B-0.01B
Income from Continuing Operations -0.64B-0.75B0.04B0.03B-0.50B-0.74B-0.59B-0.08B0.09B2.09B1.18B2.71B2.34B3.32B3.62B-0.54B
Consolidated Net Income -0.64B-0.75B0.04B-0.14B-0.18B-0.00B-0.59B-0.08B0.09B2.09B1.18B2.71B2.34B3.32B3.62B-0.54B
Income towards Parent Company -0.64B-0.75B-0.10B-0.34B-0.18B-0.02B-0.74B-0.27B0.08B2.09B1.18B2.71B2.34B3.32B3.62B-0.54B
Net Income towards Common Stockholders -0.64B-0.75B0.03B-0.34B-0.18B-0.02B-0.74B-0.27B0.08B2.09B1.18B2.71B2.34B3.32B3.62B-0.54B
Additional items
EPS (Basic) -0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B
EPS (Weighted Average and Diluted) -0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B-0.00B
Shares Outstanding (Weighted Average) 0.18B0.20B0.21B0.22B0.23B0.24B0.25B0.25B0.25B0.26B0.26B0.26B0.25B0.26B0.26B0.26B
Shares Outstanding (Diluted Average) 0.19B0.20B0.21B0.22B0.22B0.24B0.24B0.24B0.25B0.26B0.26B0.26B0.26B0.26B0.26B0.26B
EBITDA -0.61B-0.70B0.03B-0.11B-0.44B-0.69B-0.47B0.01B0.12B0.64B1.20B2.86B2.78B4.31B3.83B-0.23B
Tax Rate 31.87%19.55%15.64%13.00%14.22%21.51%17.36%